Zebra Technologies Corporation
ZBRA
$211.12
+4.08%
Zebra Technologies Corporation is a leading provider of automatic identification and data capture (AIDC) technology, offering solutions such as barcode printers and scanners, mobile computers, and workflow optimization software primarily to the retail, transportation logistics, manufacturing, and healthcare industries. The company is a dominant market leader in enterprise asset intelligence and mobility, distinguished by its comprehensive hardware and software ecosystem designed to optimize supply chain and operational efficiency. The current investor narrative revolves around balancing strong growth potential signaled by bullish guidance against evident margin pressures and a significant stock price decline, as the market debates the sustainability of its recovery amidst a challenging macroeconomic backdrop for industrial technology spending.…
ZBRA
Zebra Technologies Corporation
$211.12
Related headlines
Investment Opinion: Should I buy ZBRA Today?
Rating: Hold. The core thesis is that ZBRA presents a high-risk, high-potential-reward turnaround story where severe current fundamental weakness is balanced against deeply discounted forward valuation and analyst optimism, making it unsuitable for all but the most risk-tolerant investors awaiting a clearer inflection point.
Supporting this Hold rating are several conflicting data points. The forward P/E of 10.08x is deeply discounted and implies substantial upside if EPS targets are met, and analyst sentiment remains net positive. However, this is counteracted by a precipitous decline in Q4 net margin to 4.75%, a stock price down 29.5% YTD and nearing its 52-week low, and a high beta of 1.66 signaling elevated volatility risk. The strong TTM FCF of $831 million is a positive, but it is overshadowed by the immediate profitability crisis.
The thesis would upgrade to a Buy if the company demonstrates a clear quarter of gross margin stabilization above 46% and sequential earnings growth, confirming the recovery narrative. It would downgrade to a Sell if Q4 margin compression proves not to be an anomaly, with net income falling further below $70 million, or if revenue growth turns negative year-over-year. Relative to its own history, the stock is fairly valued for its current depressed earnings but undervalued if the forward estimates are credible; the market is pricing in a successful turnaround that is not yet evident in the reported numbers.
Sign up to view all
ZBRA 12-Month Price Forecast
The outlook for ZBRA is bifurcated, with the path determined by the speed and magnitude of its profit margin recovery. The base case of a slow, grinding stabilization is most probable (50%), given the abruptness of the Q4 deterioration. The high beta of 1.66 will magnify moves in either direction. The stance is neutral due to the offsetting forces of compelling forward valuation and alarming current fundamentals. An upgrade to bullish would require concrete evidence of margin expansion for at least two consecutive quarters. A downgrade to bearish would be triggered by a break below the $199 support level on high volume, confirming the downtrend's continuation.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Zebra Technologies Corporation's 12-month outlook, with a consensus price target around $274.46 and implied upside of +30.0% versus the current price.
Average Target
$274.46
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$169 - $274
Analyst target range
Zebra Technologies is covered by a limited cohort of 5 analysts, indicating it is a mid-cap stock with moderate institutional interest. The consensus sentiment appears cautiously optimistic, with recent institutional ratings including 'Outperform' from Baird, 'Buy' from Needham, and 'Overweight' from Barclays, balanced by 'Neutral' from Citigroup and 'Hold' from Truist Securities. The average target price is not explicitly provided in the data, but analyst estimates point to an average EPS forecast of $28.20 and average revenue forecast of $7.16 billion for the upcoming period, which can be used to gauge expectations for a financial recovery. The target price range is also not explicitly stated, but the wide dispersion between estimated EPS high ($28.72) and low ($27.55), and revenue high ($7.26B) and low ($7.03B), signals a moderate degree of uncertainty among analysts regarding the company's near-term trajectory. The pattern of recent ratings shows stability, with no downgrades in the provided data and several reiterations of positive ratings following earnings, suggesting analysts are maintaining their views despite the stock's weakness, possibly awaiting clearer signs of a fundamental inflection point.
Bulls vs Bears: ZBRA Investment Factors
The investment debate for ZBRA centers on a stark clash between deteriorating current fundamentals and the market's priced-in expectation of a powerful earnings recovery. The bear side currently holds stronger evidence, as the severe margin compression, technical breakdown, and high beta of 1.66 present immediate and quantifiable risks. However, the bull case is supported by deep-value valuation, strong cash flow, and analyst conviction. The single most important tension is whether the company can execute the dramatic profit margin expansion required to meet forward EPS estimates of $28.20. The resolution of this profitability recovery—or lack thereof—will determine if the stock is a compelling turnaround play or a value trap.
Bullish
- Strong Forward Earnings Expectations: Analysts project a significant earnings recovery, with a forward P/E of 10.08x versus a trailing P/E of 29.45x. This implies the market expects EPS to nearly triple from current depressed levels, based on an average estimate of $28.20.
- Robust Free Cash Flow Generation: The company generates substantial cash, with TTM free cash flow of $831 million. This provides a strong internal funding base for operations, debt repayment, or strategic investments, even amid profitability pressures.
- Valuation at Historical Lows: The stock trades at a trailing P/E of 29.45x, near the low end of its recent historical range (17.80x to 43.67x). This suggests significant pessimism is already priced in, offering a potential margin of safety if fundamentals stabilize.
- Analyst Sentiment Remains Constructive: Despite the stock's 29.5% annual decline, analyst ratings include 'Outperform' and 'Buy' calls with no recent downgrades. This indicates institutional belief in a long-term recovery, anchored by bullish guidance that spurred a 20% single-day gain in February.
Bearish
- Severe Profitability Compression: Q4 net income plunged to $70 million from $101 million in Q3, with net margin collapsing to 4.75% from a full-year average of 7.77%. Gross margin also compressed sharply to 44.61% from 48.03% the prior quarter, indicating significant pricing or mix pressure.
- Sustained Technical Downtrend: The stock is down 29.5% over the past year and trades just 2.5% above its 52-week low of $199.05. With a beta of 1.66, it exhibits high volatility and has underperformed the SPY by over 50 percentage points in the last year, reflecting persistent selling pressure.
- Elevated Execution Risk on Forward Estimates: The massive gap between trailing (29.45x) and forward (10.08x) P/E ratios hinges on a dramatic earnings rebound. Any stumble in achieving the $28.20 EPS target would cause severe multiple compression, given the stock's high volatility.
- Liquidity and Leverage Concerns: The current ratio of 0.97 indicates current liabilities nearly match current assets, posing a potential liquidity constraint. A debt-to-equity ratio of 0.78 shows moderate leverage, which could pressure finances if interest rates remain elevated or cash flow weakens.
ZBRA Technical Analysis
The prevailing price trend for Zebra Technologies is a pronounced and sustained downtrend, with the stock down 29.47% over the past year. As of the latest data, the stock is trading near the bottom of its 52-week range, with a current price of $202.835 compared to a 52-week high of $352.66 and a low of $199.05, positioning it at approximately 2.5% above its annual low. This deep decline suggests the stock is in a value-seeking zone but carries significant 'falling knife' risk, indicating severe negative sentiment and potential fundamental concerns. Recent short-term momentum shows continued weakness, with the stock down 10.00% over the past month and 18.31% over the past three months, accelerating the longer-term downtrend rather than signaling any reversal. The stock's 1-month relative strength of -5.72 against the SPY's -4.28% further confirms it is underperforming the broader market, indicating persistent selling pressure and a lack of near-term catalysts for recovery. Key technical levels are clearly defined, with immediate support at the 52-week low of $199.05 and major resistance at the 52-week high of $352.66. A decisive break below $199 could trigger another leg down, while any meaningful recovery would need to overcome significant overhead supply. The stock's beta of 1.655 indicates it is approximately 66% more volatile than the market, which is critical for risk management as it implies amplified moves both up and down during periods of market stress or recovery.
Beta
1.66
1.66x market volatility
Max Drawdown
-41.6%
Largest decline past year
52-Week Range
$199-$353
Price range past year
Annual Return
-5.5%
Cumulative gain past year
| Period | ZBRA Return | S&P 500 |
|---|---|---|
| 1m | -3.9% | -2.0% |
| 3m | -18.0% | -4.8% |
| 6m | -31.3% | -2.1% |
| 1y | -5.5% | +30.4% |
| ytd | -15.0% | -3.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ZBRA Fundamental Analysis
Zebra's revenue trajectory shows growth but with signs of volatility and potential deceleration; Q4 2025 revenue was $1.475 billion, representing a 10.57% year-over-year increase, yet this follows a sequential decline from Q3's $1.32 billion. Segment data reveals the Enterprise Visibility & Mobility (EVM) segment generated $865 million, significantly larger than the Asset Intelligence Tracking (AIT) segment's $455 million, indicating EVM is the primary growth driver. The multi-quarter trend shows revenue peaked in Q1 2025 at $1.308 billion and has been choppy since, suggesting growth may be stabilizing after a post-pandemic normalization phase. Profitability has come under significant pressure, with Q4 2025 net income at $70 million, a sharp drop from $101 million in Q3 and $136 million in Q1 2025. The gross margin compressed to 44.61% in Q4 from 48.03% in Q3, reflecting either pricing pressure or a less favorable sales mix. The net margin of 4.75% in Q4 is substantially below the full-year net margin indicated by key metrics (7.77%), highlighting a pronounced profitability squeeze in the most recent quarter that challenges the investment case. The balance sheet and cash flow position presents a mixed picture; the company generated strong trailing twelve-month free cash flow of $831 million, providing solid internal funding capability. However, the debt-to-equity ratio of 0.78 indicates a moderate level of leverage, and the current ratio of 0.97 suggests potential liquidity constraints with current liabilities nearly matching current assets. The ROE of 11.68% and ROA of 6.07% reflect adequate but not exceptional returns on capital, implying the company is generating cash but not with exceptional efficiency given the recent profit decline.
Quarterly Revenue
$1.5B
2025-12
Revenue YoY Growth
+0.10%
YoY Comparison
Gross Margin
+0.44%
Latest Quarter
Free Cash Flow
$831000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ZBRA Overvalued?
Given that net income is positive ($70 million in Q4), the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 29.45x, while the forward PE is significantly lower at 10.08x, indicating the market expects a substantial recovery in earnings over the next twelve months. The wide gap between trailing and forward multiples suggests current earnings are considered depressed, and analysts are pricing in a robust earnings rebound, which carries execution risk. Compared to sector averages, Zebra's trailing PE of 29.45x is difficult to contextualize precisely without a provided industry average, but its Price-to-Sales (PS) ratio of 2.29x and EV/Sales of 2.33x offer alternative benchmarks. A gross margin of 45.94% and operating margin of 14.83% are healthy for a hardware-centric business, potentially justifying a moderate premium if growth resumes, but the recent margin compression tempers that thesis. Historically, the stock's current trailing PE of 29.45x sits well below its own historical range observed in recent quarters, where it has traded as high as 43.67x (Q4 2025) and as low as 17.80x (Q4 2022). This positioning near the lower end of its historical valuation band suggests the market has already priced in significant pessimism, potentially offering a value opportunity if the company can execute a turnaround, but it also reflects genuine fundamental deterioration that must be addressed.
PE
29.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -202x~206x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced, centered on a severe and recent profitability squeeze. Q4 net income of $70 million represents a 31% sequential drop and a 57% decline from Q1 2025, while gross margin compressed 342 basis points quarter-over-quarter to 44.61%. This margin pressure, if sustained, directly threatens the forward P/E thesis. Furthermore, a current ratio of 0.97 indicates tight liquidity, and a debt-to-equity of 0.78 adds financial leverage risk in a higher-rate environment. Revenue concentration in the cyclical Enterprise Visibility & Mobility segment (59% of Q4 sales) also exposes the company to downturns in retail, logistics, and manufacturing spending.
Market & Competitive Risks are elevated due to ZBRA's high volatility and valuation positioning. The stock's beta of 1.655 means it is 66% more volatile than the market, amplifying downside during risk-off periods. While the trailing P/E of 29.45x is below its own historical average, it remains a premium valuation that requires growth to justify; any deceleration could trigger further multiple compression. The company operates in the competitive industrial technology and communication equipment space, where prolonged macroeconomic softness could delay customer capital expenditure decisions, pressuring top-line growth beyond the current choppiness.
Worst-Case Scenario involves a failure to arrest the margin decline, leading to a material miss against the $28.20 forward EPS estimate. This could trigger analyst downgrades, a loss of investor confidence, and a re-rating toward the stock's historical P/E low of 17.80x. Combined with a broader market sell-off amplified by its high beta, the stock could breach its 52-week low of $199.05 and approach levels seen during prior stress periods. A realistic downside from the current price of ~$202.84 could be -20% to -25%, targeting a range of $152-$162, which would align with a P/E in the mid-teens on depressed earnings.
FAQ
The key risks are, in order of severity: 1) Profitability Risk: The severe compression in Q4 net margin to 4.75% may continue, derailing the earnings recovery thesis. 2) Execution Risk: The stock's valuation hinges on nearly tripling EPS to $28.20; any shortfall could cause a sharp decline. 3) Macro & Market Risk: ZBRA's high beta of 1.66 amplifies losses in a down market, and its cyclical end-markets (retail, logistics) are sensitive to economic slowdowns. 4) Financial Risk: A current ratio of 0.97 indicates tight liquidity, and a debt-to-equity of 0.78 adds leverage pressure.
The 12-month forecast is highly scenario-dependent. The base case (50% probability) sees the stock trading between $240 and $280 as it stabilizes but delivers a slower-than-hoped earnings recovery. The bull case (25% probability) projects a rally to $300-$352 if margin recovery is swift and EPS targets are met. The bear case (25% probability) warns of a drop to $160-$200 if profitability worsens and estimates are cut. The base case is most likely, assuming the company manages to stop the margin bleed but struggles to quickly return to peak profitability. The key assumption is that gross margins stabilize in the coming quarter.
ZBRA's valuation sends mixed signals, making it context-dependent. Based on depressed trailing earnings (P/E of 29.45x), it appears fairly valued or slightly expensive. However, based on forward earnings expectations (P/E of 10.08x), it appears deeply undervalued. The market is thus pricing in a substantial earnings rebound. Compared to its own historical P/E range (17.80x to 43.67x), the current trailing multiple is near the lower end, suggesting pessimism is priced in. The valuation implies the market expects a successful profit recovery; if that occurs, the stock is undervalued. If not, it is overvalued.
ZBRA is a high-risk, high-potential-reward stock that may be a good buy only for specific investors. The forward P/E of 10.08x offers compelling upside if the company hits its EPS target of ~$28.20, implying a significant recovery. However, this is counterbalanced by severe recent margin compression, a stock down 29.5% in a year, and high volatility (beta 1.66). It is a good buy for risk-tolerant, patient investors betting on a successful turnaround, but a poor choice for those seeking stability or with a short time horizon. The biggest risk is that the earnings recovery fails to materialize.
ZBRA is unsuitable for short-term trading due to its high volatility (beta 1.66) and lack of near-term positive catalysts; the prevailing trend is strongly negative. It is a candidate only for long-term investment (minimum 2-3 year horizon) by investors who believe in the company's market position and its ability to execute a multi-quarter turnaround. The investment thesis is based on a fundamental recovery that will take time to unfold and verify. Given the absence of a dividend, the total return is purely dependent on capital appreciation from this recovery, which is a longer-cycle event.